Literature DB >> 19846332

A timeline for Parkinson's disease.

Christopher H Hawkes1, Kelly Del Tredici, Heiko Braak.   

Abstract

It is reasonably well established that prior to the motor phase of classical Parkinson's disease (PD) there is a prodromal period of several years duration. Once typical motor features appear, the disease continues up to 20 years depending on multiple variables. The clinical features of the prodromal and motor phases may be correlated with pathological changes in the central and autonomic nervous systems to allow a sequential plan of disease progression. We present a 'best guess' for a typical individual presenting with PD in their sixties and speculate that the disease will last approximately 40 years from the earliest non-motor features to death. Appreciation of this concept may allow better strategies for slowing or halting disease progression. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19846332     DOI: 10.1016/j.parkreldis.2009.08.007

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  175 in total

1.  Superficial siderosis associated with abundant τ and α-synuclein accumulation.

Authors:  Masaki Takao; Shigeo Murayama; Youji Yoshida; Ban Mihara
Journal:  BMJ Case Rep       Date:  2011-12-01

2.  Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.

Authors:  Jon B Toledo; Pallavi Gopal; Kevin Raible; David J Irwin; Johannes Brettschneider; Samantha Sedor; Kayla Waits; Susana Boluda; Murray Grossman; Vivianna M Van Deerlin; Edward B Lee; Steven E Arnold; John E Duda; Howard Hurtig; Virginia M-Y Lee; Charles H Adler; Thomas G Beach; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2015-12-31       Impact factor: 17.088

Review 3.  Neurotoxins as Preclinical Models for Parkinson's Disease.

Authors:  Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-01-08       Impact factor: 3.911

4.  Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease.

Authors:  Deniz Kahraman; Carsten Eggers; Harald Schicha; Lars Timmermann; Matthias Schmidt
Journal:  J Neurol       Date:  2011-07-13       Impact factor: 4.849

5.  α-Synuclein in gut endocrine cells and its implications for Parkinson's disease.

Authors:  Rashmi Chandra; Annie Hiniker; Yien-Ming Kuo; Robert L Nussbaum; Rodger A Liddle
Journal:  JCI Insight       Date:  2017-06-15

Review 6.  Parkinson's disease as a multisystem disorder.

Authors:  Lisa Klingelhoefer; H Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2017-02-02       Impact factor: 3.575

Review 7.  Milestones in research on the pathophysiology of Parkinson's disease.

Authors:  Thomas Wichmann; Mahlon R DeLong; Jorge Guridi; Jose A Obeso
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 8.  The deep brain stimulation of the pedunculopontine tegmental nucleus: towards a new stereotactic neurosurgery.

Authors:  Paolo Mazzone; Stefano Sposato; Angelo Insola; Eugenio Scarnati
Journal:  J Neural Transm (Vienna)       Date:  2011-02-12       Impact factor: 3.575

Review 9.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

10.  Early-onset Parkinsonian behaviors in female Pink1-/- rats.

Authors:  Julia M Marquis; Samantha E Lettenberger; Cynthia A Kelm-Nelson
Journal:  Behav Brain Res       Date:  2019-09-19       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.